Form 8-K - Current report:
SEC Accession No. 0001479681-25-000024
Filing Date
2025-05-13
Accepted
2025-05-13 16:31:29
Documents
16
Period of Report
2025-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nutx-20250513x8k.htm   iXBRL 8-K 29780
2 EX-99 nutx-20250513xex99.htm EX-99 327044
3 GRAPHIC nutx-20250513xex99001.jpg GRAPHIC 4252
  Complete submission text file 0001479681-25-000024.txt   512499

Data Files

Seq Description Document Type Size
4 EX-101.SCH nutx-20250513.xsd EX-101.SCH 4128
5 EX-101.DEF nutx-20250513_def.xml EX-101.DEF 2857
6 EX-101.LAB nutx-20250513_lab.xml EX-101.LAB 17255
7 EX-101.PRE nutx-20250513_pre.xml EX-101.PRE 11371
18 EXTRACTED XBRL INSTANCE DOCUMENT nutx-20250513x8k_htm.xml XML 4831
Mailing Address 6030 S. RICE AVE. SUITE C HOUSTON TX 77081
Business Address 6030 S. RICE AVE. SUITE C HOUSTON TX 77081 (713) 660-0557
Nutex Health, Inc. (Filer) CIK: 0001479681 (see all company filings)

EIN.: 113363609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41346 | Film No.: 25940671
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)